Home
About
Overview
Sharing Data
ORCID
Help
History (26)
Efficacy of ruxolitinib cream in vitiligo by patient characteristics and affected body areas: Descriptive subgroup analyses from a phase 2, randomized, double-blind trial.
Neurosonology and noninvasive imaging of the carotid arteries.
Exploring the Evolutionary History of Kinetic Stability in the a-Lytic Protease Family.
Age at menopause and determinants of hysterectomy and menopause in a multi-ethnic community: the Hilo Women's Health Study.
Acute emesis: moderately emetogenic chemotherapy.
See All 26 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Acute emesis: moderately emetogenic chemotherapy.
Herrstedt J, Koeller JM, Roila F, Hesketh PJ, Warr D, Rittenberg C, Dicato M. Acute emesis: moderately emetogenic chemotherapy. Support Care Cancer. 2005 Feb; 13(2):97-103.
View in:
PubMed
subject areas
Acute Disease
Antiemetics
Antineoplastic Agents
Drug Administration Routes
Drug Administration Schedule
Humans
Practice Guidelines as Topic
Randomized Controlled Trials as Topic
Vomiting
authors with profiles
Paul Joseph Hesketh MD